UKY-26778-13370
3 vaccinations
1 coded response
28 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 300 / GA
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Dose 1 — Pfizer-BioNTech
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-14
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-28
- 2021-02-05
- 2021-02-11
- 2021-02-19
- 2021-02-25
- 2021-04-20
- 2021-07-15
-
2021-09-25
Dose 3 — Pfizer-BioNTech
- 2021-09-25
-
2021-09-26
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-09-28
- 2021-09-29
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-12-25
-
2022-03-28
Survey response — 6 months, dose 3MedDRA: Oropharyngeal pain, Parosmia, Respiratory tract congestion, Taste disorder — Feeling: Good · Be unable to work or attend schoolFree text: Congestion, sore throat, altered taste/smellMedDRA releases: 2024-11 · check-in free text available
- 2022-09-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: Congestion, sore throat, altered taste/smell
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Taste disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release